GeneDx Holdings (WGS) Return on Capital Employed (2020 - 2026)
GeneDx Holdings (WGS) posted quarterly Return on Capital Employed of 15.44% for Q1 2026, down 1156.0% year-over-year from 1.46% in Q1 2025, and down 372.24% quarter-over-quarter from 3.27% in Q4 2025.
GeneDx Holdings (WGS) Return on Capital Employed (2020 - 2026) Analysis & Trends
GeneDx Holdings (WGS) has reported Return on Capital Employed for 7 consecutive years, with 15.44% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed fell 1156.0% year-over-year to 15.44%; the TTM figure through Mar 2026 stood at 15.44% (down 1156.0% YoY), while the FY2025 annual figure was 3.61%, up 277.0% from the prior year.
- Return on Capital Employed retreated to 15.44% in Q1 2026 per WGS's latest filing, from 3.27% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 2.55% in Q3 2025 and bottomed at 160.04% in Q1 2023.
- Historically, Return on Capital Employed has averaged 54.64% across 5 years, with a median of 37.62% in 2024.
- Annual changes were most pronounced in 2022 — Return on Capital Employed soared 25153 bps — and 2023, when it sank 8220 bps.
- GeneDx Holdings' Return on Capital Employed stood at 129.47% in 2022, then soared by 61 bps to 50.28% in 2023, then surged by 87 bps to 6.46% in 2024, then surged by 49 bps to 3.27% in 2025, then plunged by 372 bps to 15.44% in 2026.
- Business Quant data shows WGS's Return on Capital Employed at 15.44% in Q1 2026, 3.27% in Q4 2025, and 2.55% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 8.30% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.42% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 68.60% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 14.57% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 10.49% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -16.64% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 17.55% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 49.80% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 10.85% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | -22.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.04% |
| Mar 31, 2026 | -15.44% |
| Dec 31, 2025 | -3.27% |
| Sep 30, 2025 | 2.55% |
| Jun 30, 2025 | 1.42% |
| Mar 31, 2025 | -3.88% |
| Dec 31, 2024 | -6.46% |
| Sep 30, 2024 | -17.93% |
| Jun 30, 2024 | -28.70% |
| Mar 31, 2024 | -37.62% |
| Dec 31, 2023 | -50.28% |
| Sep 30, 2023 | -126.78% |
| Jun 30, 2023 | -123.73% |
| Mar 31, 2023 | -160.04% |
| Dec 31, 2022 | -129.47% |
| Sep 30, 2022 | -63.79% |
| Jun 30, 2022 | -87.55% |
| Mar 31, 2022 | -77.84% |
| Dec 31, 2021 | -93.45% |
| Sep 30, 2021 | -143.29% |